Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine–pyrimethamine in central Africa: a cross-sectional study

Desai, 2007, Epidemiology and burden of malaria in pregnancy, Lancet Infect Dis, 7, 93, 10.1016/S1473-3099(07)70021-X Cairns, 2020, Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali, PLoS Med, 17, 10.1371/journal.pmed.1003214 Naidoo, 2013, Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria, Trends Parasitol, 29, 505, 10.1016/j.pt.2013.08.002 Roper, 2004, Intercontinental spread of pyrimethamine-resistant malaria, Science, 305, 10.1126/science.1098876 Pearce, 2009, Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria, PLoS Med, 6, 10.1371/journal.pmed.1000055 Sutherland, 2009, Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom, Antimicrob Agents Chemother, 53, 3405, 10.1128/AAC.00024-09 Chauvin, 2015, Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles, J Antimicrob Chemother, 70, 2566, 10.1093/jac/dkv160 Beshir, 2023, Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study, Lancet Infect Dis, 23, 361, 10.1016/S1473-3099(22)00593-X 2013 Roper, 2003, Antifolate antimalarial resistance in southeast Africa: a population-based analysis, Lancet, 361, 1174, 10.1016/S0140-6736(03)12951-0 Goudet, 1995, FSTAT (version 1.2): a computer program to calculate F-statistics, J Hered, 86, 485, 10.1093/oxfordjournals.jhered.a111627 Oyola, 2016, Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification, Malar J, 15, 597, 10.1186/s12936-016-1641-7 Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 Ahouidi, 2021, An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples, Wellcome Open Res, 6, 42, 10.12688/wellcomeopenres.16168.1 Jombart, 2011, adegenet 1.3-1: new tools for the analysis of genome-wide SNP data, Bioinformatics, 27, 3070, 10.1093/bioinformatics/btr521 Quinlan, 2010, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, 26, 841, 10.1093/bioinformatics/btq033 Alam, 2011, Tracking origins and spread of sulfadoxine–resistant Plasmodium falciparum dhps alleles in Thailand, Antimicrob Agents Chemother, 55, 155, 10.1128/AAC.00691-10 Beghain, 2016, Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes, Malar J, 15, 206, 10.1186/s12936-016-1258-x Lee Witkowski, 2017, A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, 17, 174, 10.1016/S1473-3099(16)30415-7 Claessens, 2018, RecQ helicases in the malaria parasite Plasmodium falciparum affect genome stability, gene expression patterns and DNA replication dynamics, PLoS Genet, 14, 10.1371/journal.pgen.1007490 Naidoo, 2011, Drug resistance maps to guide intermittent preventive treatment of malaria in African infants, Parasitology, 138, 1469, 10.1017/S0031182011000746 van Eijk, 2019, Effect of Plasmodium falciparum sulfadoxine–pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis, Lancet Infect Dis, 19, 546, 10.1016/S1473-3099(18)30732-1 Gosling, 2009, Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial, Lancet, 374, 1521, 10.1016/S0140-6736(09)60997-1 Desai, 2016, Impact of sulfadoxine–pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight, Clin Infect Dis, 62, 323, 10.1093/cid/civ881 Deutsch-Feldman, 2019, The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo, BMC Infect Dis, 19, 872, 10.1186/s12879-019-4523-0 Rosillo, 2023, Molecular markers of sulfadoxine–pyrimethamine resistance in samples from children with uncomplicated Plasmodium falciparum at three sites in Angola in 2019, Antimicrob Agents Chemother, 67, 10.1128/aac.01601-22 Zhao, 2021, Surveillance of antimalarial drug-resistance genes in imported Plasmodium falciparum isolates from Nigeria in Henan, China, 2012–2019, Front Cell Infect Microbiol, 11, 10.3389/fcimb.2021.644576 Plowe, 2009, The evolution of drug-resistant malaria, Trans R Soc Trop Med Hyg, 103, S11, 10.1016/j.trstmh.2008.11.002 Cohen, 2023, Effect of sulfadoxine–pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation, J Antimicrob Chemother, 78, 665, 10.1093/jac/dkac432 Ndu, 2020, Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria, Malawi Med J, 32, 45, 10.4314/mmj.v32i1.9